Overview
- 34 inspections across 33 sites are on record.
- 8 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-07-28.
At a glance
Inspections
34
Sites
33
Observations
8
Career since
Jul 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| QUOTIENT SCIENCES (ALNWICK) LIMITED | 28 Jul 2023 | Human Drugs | |
| AnaZeal Analyticals & Research Pvt. Ltd. | 9 Jun 2023 | Human Drugs | |
| Sciegen Pharmaceuticals Inc | 21 Apr 2023 | Human Drugs | On file |
| SPS Pharma Services | 7 Feb 2020 | Human Drugs | On file |
| Enem Nostrum Remedies Pvt. Ltd | 31 Jan 2020 | Human Drugs |
Sites inspected
QUOTIENT SCIENCES (ALNWICK) LIMITEDAlnwick, United Kingdom1 insp.
AnaZeal Analyticals & Research Pvt. Ltd.Navi Mumbai, India1 insp.
Sciegen Pharmaceuticals IncHauppauge, United States1 insp.
SPS Pharma ServicesOrleans, France1 insp.
Enem Nostrum Remedies Pvt. LtdMumbai, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Melkamu Getie Kebtie4 shared
Sripal R Mada4 shared
Mohsen Rajabi Abhari3 shared
Li-Hong Yeh2 shared
Michael F Skelly2 shared
Joanne M Schlossin2 shared
Gulshan R Anand2 shared
John A Iwen2 shared
Matthew R Palo2 shared
Craig A Garmendia1 shared
Full investigator report
Get the verbatim findings behind Xikui Chen's 8 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site